Clinical Trials Browser

Carcinoid Tumor × cabozantinib × NET × Clear all

NCT05263050 2026-05-22

Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

Phase 2 Recruiting

EndocrineGenitourinaryNET

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT04197310 2025-01-31

Cabozantinib and Nivolumab for Carcinoid Tumors

Phase 2 Completed

19 enrolled 10 charts

Carcinoid Tumor, Neuroendocrine Tumors